AI’s Expansion Into Clinical Research Should Excite Us
AI can accelerate clinical research and medicine, but its value will depend on data quality, patient protection, governance, and continued human judgment.
Not Every AI Model Should Be Consumer-Grade
As frontier AI becomes more powerful, access itself becomes part of the safety architecture. High-risk models require governance, verification, and accountability.
Token-Maxxing: When AI Metrics Replace Common Sense
The AI industry has developed an unhealthy obsession with a metric that should have never become a goal: usage. More tokens. More prompts. More AI interactions. More AI-generated code. More AI-generated content. The assumption seems to be that greater AI usage automatically translates into greater productivity. It does not. In many cases, it translates into…
Why Model Behavior Has to Be Studied, Not Assumed
Model behavior should not be assumed. VIQ™ is entering its next research phase: telemetry-based study of safety, efficacy, and governed AI routing.
AI Will Not Replace Humans. It Will Expose Them.
In an already stressed job market, people are experiencing anxiety and fatigue about the future of AI and what it means for them. Layoffs over the past few years are increasingly being attributed to AI - rather than overhiring during the pandemic, shifting market conditions, or performance gaps. With the release of the VIQ™ Phase…
Phase 3 is Live - And VIQ™ Has Something to Say About AI Slop
VIQ™ Demo Phase 3 dropped this morning. The Adaptive Memory & Context Evolution Expansion introduces session coherence and a system that remembers what you told it three prompts ago. It builds on it instead of starting over like a goldfish. But I don't want to just talk about what's new. I want to talk about…
Research Disclaimer
Anonymized session telemetry is collected for system performance research. No personally identifiable information is stored. All user identifiers are one-way cryptographically hashed prior to logging. See our Terms of Use for full data and privacy disclosures - Section 7.